A warning for US science & wool’s chemical versatilitynews2026-06-24T11:45:00+00:00June 24th, 2026|Chemistry World|
Ollin nets $330M to run Phase 3 trials of Vabysmo challenger from Chinanews2026-06-24T11:00:52+00:00June 24th, 2026|Endpoints News|
RQ Bio secures $115M Series A for virus-targeting antibody pipelinenews2026-06-24T10:40:52+00:00June 24th, 2026|Endpoints News|
Lilly offers up to $1.9B in new drug discovery deal with Abbiskonews2026-06-24T10:14:04+00:00June 24th, 2026|Endpoints News|
Europe MEK pricing widens on muted demandnews2026-06-24T09:06:00+00:00June 24th, 2026|Independent Commodity Intelligence Services (ICIS)|
